about
Continued cognitive-behavior therapy versus sertraline for children and adolescents with obsessive-compulsive disorder that were non-responders to cognitive-behavior therapy: a randomized controlled trialTics Moderate Sertraline, but Not Cognitive-Behavior Therapy Response in Pediatric Obsessive-Compulsive Disorder Patients Who Do Not Respond to Cognitive-Behavior Therapy.The Nordic long-term OCD treatment study (NordLOTS): rationale, design, and methods.Predictors associated with improved cognitive-behavioral therapy outcome in pediatric obsessive-compulsive disorder.1H magnetic resonance spectroscopy evidence for occipital involvement in treatment-naive paediatric obsessive-compulsive disorder.Structure and clinical correlates of obsessive-compulsive symptoms in a large sample of children and adolescents: a factor analytic study across five nations.Subclinical autism spectrum symptoms in pediatric obsessive-compulsive disorder.Autism spectrum traits in children and adolescents with obsessive-compulsive disorder (OCD).Effectiveness of cognitive behavior treatment for pediatric obsessive-compulsive disorder: acute outcomes from the Nordic Long-term OCD Treatment Study (NordLOTS).The Internet Intervention Patient Adherence Scale for Guided Internet-Delivered Behavioral Interventions: Development and Psychometric EvaluationDistinct trajectories of long-term symptom severity in pediatric obsessive-compulsive disorder during and after stepped-care treatmentTreatment Gains Are Sustainable in Pediatric Obsessive-Compulsive Disorder: Three-Year Follow-Up From the NordLOTSConvergent and divergent validity of the schedule for affective disorders and schizophrenia for school-age children - present and lifetime version diagnoses in a sample of children and adolescents with obsessive-compulsive disorder
P50
Q35568012-5001C950-B6D5-4CD1-91BF-8676F6BA56C5Q35816517-1B950E7B-3461-4754-A78B-6BE513A69817Q37426116-EE77D1EF-47F7-4E63-BCBB-81839B3FCAB9Q38365635-1D76DA27-0408-42C5-A2A0-DB5E51FC5DA2Q39257738-D4412F58-632D-40B2-B20E-415CB70BA42CQ39623701-745F1F8F-6A77-4390-AF94-F1F18A020304Q40373805-1DBE8886-7620-4EC4-95A2-9F0BF179DAE6Q50311463-B14FB6AC-B96F-4A46-9EF8-4BC0846E2EA6Q50608517-63151461-8E7A-42F3-B878-D85133C435BFQ90412114-CDDF6E31-4EC2-4426-AAD5-B588C80CF4CDQ91313544-A2EC693F-2F2E-4578-BF1F-345D5F45C3D8Q91618164-2AFC4455-EAC0-4E8D-B776-D8AE7F65B54BQ92355713-F16BDADA-6968-422D-B7DC-A6FEA0F60AE1
P50
description
Sahlgrenska Universitetssjukhuset
@sv
Sahlgrenska Universitetssjukhuset, Gothenburg, Sweden
@en
wetenschapper
@nl
name
Karin Melin
@en
Karin Melin
@nl
Karin Melin
@sv
type
label
Karin Melin
@en
Karin Melin
@nl
Karin Melin
@sv
prefLabel
Karin Melin
@en
Karin Melin
@nl
Karin Melin
@sv
P2038
Karin_Melin
P31
P496
0000-0002-3297-7735